Skip to main content
Signal8
Launch Terminal
Shapiro Aron profile photo

Aron Shapiro

CIK: 0001855207

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KIORA PHARMACEUTICALS INC logo
KPRX

KIORA PHARMACEUTICALS INC

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Jun 10, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    25K shares-
  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Apr 1, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    20K shares-
  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Sep 10, 2024
    Purchase(P)
    Indirect
    3K shares at avg. $3.60$11K

1-3 of 3

About Shapiro Aron

Shapiro Aron (SEC CIK 0001855207) files insider reports with the SEC as Director of KIORA PHARMACEUTICALS INC (KPRX).

Signal8 holds 3 ownership filings by Shapiro Aron, all Form 4s, filed between Sep 11, 2024 and Jun 12, 2026. Those filings report 3 transactions, from Sep 10, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Shapiro Aron's filings is in ENCINITAS, CA.

Recent filings by Shapiro Aron

  • Jun 10, 2026: Grant or award of KPRX derivative securities (Form 4, code A).
  • Apr 1, 2025: Grant or award of KPRX derivative securities (Form 4, code A).
  • Sep 10, 2024: Open-market purchase of KPRX shares (Form 4, code P).

Other insiders filing for KIORA PHARMACEUTICALS INC (KPRX)

How to read Form 4 transaction codes